Skip to main content
← All exclusions

Lexicon Pharmaceuticals, Inc.

LXRX

Health Care

1

exclusion reason

1 theme

Animal Welfare (1)
LXRX Health Care Current as of March 2026

This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.

Animal Testing & Research
Since Jul 28, 2021

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company whose core business of discovering and developing novel medicines relies on animal testing as a standard part of its preclinical research and regulatory compliance. The company’s SEC filings explicitly list “preclinical laboratory and animal tests” and “toxicology studies” as integral components of its drug development process. This includes the creation and use of genetically modified animal models, such as the Qdpr mutant mice produced by Lexicon for research purposes. As a pharmaceutical entity, the company’s operations inherently involve funding, conducting, and relying on animal testing to advance its product pipeline, including its licensed drug candidate LX9851.

Research Sources 1 organization
Cruelty Free Investors
External

Wondering what we do invest in?

The Naughty List

A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.

RSS feed No spam · Unsubscribe anytime

Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.

This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.

Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.